CAJ | 학술논문

目的：探讨急性脑梗死治疗疗效。方法：2001年1月-2012年12月收治急性脑梗死患者73例，分为红花组(A组)、依达拉奉组(B组)、红花+依达拉奉组(C组)；常规治疗基础上分别给予A组红花注射液20 mL，静脉滴注，1次/d；B组依达拉奉注射液，30 mg/次，静脉滴注，2次/d；C组红花注射液20 mL，1次/d+依达拉奉注射液30 mg/次静脉滴注，2次/d；15 d后分别观察各组梗死面积；采用ADL分级法评估6个月时良好恢复率。结果：A和B组15 d梗死面积无明显差别(P＞0.05)，C组15 d梗死面积与A、B组相比较差异有统计学意义(P＜0.05)，6个月后B、C组良好恢复率明显好于A组(P＜0.05)。结论：红花注射液联合依达拉奉注射液联合治疗急性脑梗死良好临床疗效。
목적：탐토급성뇌경사치료료효。방법：2001년1월-2012년12월수치급성뇌경사환자73례，분위홍화조(A조)、의체랍봉조(B조)、홍화+의체랍봉조(C조)；상규치료기출상분별급여A조홍화주사액20 mL，정맥적주，1차/d；B조의체랍봉주사액，30 mg/차，정맥적주，2차/d；C조홍화주사액20 mL，1차/d+의체랍봉주사액30 mg/차정맥적주，2차/d；15 d후분별관찰각조경사면적；채용ADL분급법평고6개월시량호회복솔。결과：A화B조15 d경사면적무명현차별(P＞0.05)，C조15 d경사면적여A、B조상비교차이유통계학의의(P＜0.05)，6개월후B、C조량호회복솔명현호우A조(P＜0.05)。결론：홍화주사액연합의체랍봉주사액연합치료급성뇌경사량호림상료효。
Objective:To investigate the curative effect of acute cerebral infarction.Methods:73 patients with acute cerebral infarction were selected from January 2001 to December 2012.They were divided into the Honghua injection group(group A),the edaravone group(group B),the Honghua and edaravone group(group C);based on the conventional treatment,patients in the group A were given 20 mL of Honghua injection with intravenous drip,1 times/d;the group B were given edaravone injection 30 mg/time, intravenous drip,2 times/d;the group C were given 20 mL of Honghua injection,1 time/d combined with edaravone injection 30 mg/time,intravenous infusion,2 times/d;after treated for 15 days,we observed the infarction area in three groups;assessment the recovery rate in 6 months with ADL classification method.Results:There was no significant difference in infarction area of 15 d between A and B group(P>0.05),while infarction area of 15 d in the C group was significantly different with A and B groups(P<0.05),after 6 months of treatment,the good recovery rate of B and C group were both significantly better than the A group(P<0.05). Conclusion:Honghua injection combined with edaravone injection in the treatment of acute cerebral infarction has curative effect.